Funding profile · Healthcare AI, clinical operations
Ankr Health
A Y Combinator Winter 2022 company with one seed round on record from a private data provider and no SEC Form D on file under its own name. Here is what can and cannot be confirmed about its money.
Data as of September 25, 2026. Company-reported figures are labeled. Where a figure comes from a private data provider rather than a government filing, it is labeled unverified.
Rounds at a glance
| When | Round | Amount | Investors | Source |
|---|---|---|---|---|
| Mar 2022 | Y Combinator, Winter 2022 | Not disclosed | Y Combinator | YC data |
| Mar 4, 2022 | Incorporation, Ankr Health Corp. | Not applicable | Not applicable | Tracxn, unverified |
| Mar 29, 2022 | Seed | $500,000, post-money valuation redacted in public view | Y Combinator; WorldQuant Ventures named separately by Parsers.vc | Tracxn, unverified |
| Jun 2023 | Non-equity assistance | Amount not disclosed | Not disclosed | Bounce Watch, unverified |
| 2023 | MedTech Innovator accelerator, 2023 cohort | No cash prize reported for Ankr specifically; program-wide prizes total $800,000 with a $350,000 grand prize | MedTech Innovator | Independent |
| Nov 2021 | Ion Startup Showcase win | $10,000 cash plus free legal services | Rice University’s Ion; Baker Botts (legal services) | Independent |
What the filings show
Nothing. A direct search of SEC EDGAR’s company database for “Ankr Health” returns no filer at all, in any form type. A broader search for “Ankr” turns up exactly one Form D filer, “Ankr, a Series of Hack VC Investments II LLC,” a Utah-registered investment vehicle tied to the blockchain infrastructure company Ankr, a different business with no apparent connection to Ankr Health beyond the shared name. No Form D, no amendment, and no related SEC filing of any kind exists for Ankr Health Corp. as of this research.
Reading the record
- The one funding figure on record did not come from a government filing.The $500,000 seed close reported for March 29, 2022 comes from Tracxn, a private company data and analytics provider, not from an SEC filing or a company press release. Tracxn also redacts the round’s post-money valuation in its public view.
- No Form D means either an exemption, or a raise too small to require one, or simply that this record has not been filed.Companies raising under other exemptions, or through convertible instruments that some counsel treats as outside Regulation D’s notice requirement, can legally raise money with no Form D on EDGAR at all. The absence of a filing here is a gap in the public record, not proof that no money moved.
- Two data providers disagree about whether Ankr Health has raised any money.GetLatka’s company page states plainly, “We do not have funding information about Ankr Health yet,” and separately, “No funding has been reported for Ankr Health yet.” That directly conflicts with Tracxn’s $500,000 seed round record for the same company.
- The company’s own revenue estimate contradicts itself.GetLatka’s page lists Ankr Health at $2.3 million in revenue for December 2024, but the same page’s milestone table also lists $4.5 million for June 2024, a fall of roughly half within six months on the page’s own numbers. Neither figure is described as company-confirmed; both are labeled estimates.
- Accelerator money is smaller and better documented than the seed round.The $10,000 Ion Startup Showcase prize, reported by the Houston Chronicle in 2021, is the only dollar figure in this profile that comes from an independent news outlet rather than a data aggregator or the company itself.
- The company has not announced a named round since 2022.No press release, term sheet, or later Form D naming a Series A, Series B, or bridge round was found. The most recent activity found is product and go-to-market material from 2025 and 2026 describing two new products, Ankr 4X for pharma and Ankr VCX for clinics, with no accompanying funding announcement.
Commercial signals
| Signal | Detail | Source type |
|---|---|---|
| Accelerators | Y Combinator Winter 2022 batch; MedTech Innovator 2023 cohort, one of 61 companies chosen from nearly 1,200 applicants. | Public record / Independent |
| Early traction | By Nov 2021, reported to serve 26 clinics and more than 50,000 patients through its original cancer navigation app. | Independent |
| Named customers | None. Company materials describe an unnamed 22-clinic health system in Minnesota and Wisconsin, over 300 additional doctors across five states, and a pharma contract following diligence from two unnamed top-five pharma companies, with a podcast description separately naming AstraZeneca as a pharma partner. | Company-stated |
| EHR integrations | Describes itself as a marketplace partner for Athena, eClinicalWorks, Epic and Greenway. | Company-stated |
| Employees | 15 as of 2026, per Tracxn; GetLatka’s own page separately lists 30 employees for two different points in 2024. | Conflicting estimates |
What to watch
- Any Form D filed under Ankr Health Corp. or a related entity name, which would be the first primary-source funding record for this company.
- Resolution of the GetLatka revenue and funding conflicts described above.
- Whether the AstraZeneca relationship mentioned in an independent podcast description is confirmed by either party.
- Named clinic or health system customers for the current Ankr VCX product line.
The Ankr Health story on Healthcare DiscoveryHealthcare Discovery
Related companies
Sources
- Public recordEDGAR company search, “ankr health”, no results
- Public recordEDGAR company search, “ankr”, Form D for Ankr, a Series of Hack VC Investments II LLC
- Public recordAnkr Health: Virtualizing brick-mortar infrastructures of clinics w/ generative AI
- Independent, unverifiedAnkr company profile, incorporation and funding record
- Independent, unverifiedAnkr Health (YC W22), investors and press mentions
- Independent, unverifiedAnkr Health Revenue 2024: $2.3M Est. ARR
- Independent, unverifiedAnkr Health funding and signals
- IndependentCancer care firm Ankr wins Ion’s first startup showcase
- Independent4 Houston startups selected for preeminent medtech accelerator
- IndependentFrom Oncology to Building AI for Pharma, episode description
- CompanyAnkr VCX, AI Workforce for Medical Practices, home page
- CompanyAnkr for your health system, partner page
- CompanyRay Rao at JPM 2025, Ankr 4X conference page
Compiled from SEC and other public records and published reports as of September 25, 2026. Form D notices report offerings under Regulation D; no such notice was found for Ankr Health as of this research. Private data providers cited here are not government filings and their figures are labeled unverified. Healthcare Venture Capital Fund holds no position in Ankr Health. This page is not an offer to sell or a recommendation to buy any security.